GPC3 and B-cell chronic lymphocytic leukemia: We found the co-expression of TFPI and GPC3 on the surface of CLL cells and co-IP confirmed the binding between the two proteins, which is consistent with previous studies on the hepatocellular carcinoma cell line HepG233 and hematopoietic stem cells20.